Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cyproheptadine + sorbitol + tricholine citrate
- Development stage
- Unknown
- Lead developer
- Caplet India
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Choliv is an oral combination therapy developed by Caplet India, formulated as a syrup or drops, containing cyproheptadine, tricholine citrate, and sorbitol. It is primarily indicated as an appetite stimulant and digestive aid to treat anorexia, support weight gain, and manage malnutrition in both children and adults. Cyproheptadine acts as an antihistamine and serotonin antagonist, targeting the hypothalamus to stimulate appetite. Tricholine citrate serves as a lipotropic and bile acid-binding agent that mobilizes fat from the liver, supporting hepatic function and improving digestion. Sorbitol acts as an osmotic laxative to prevent constipation and serves as a pharmaceutical syrup base. Choliv is approved and marketed in India.
- Brand names
- CholivCholiv DropCholiv LCholiv Syrup
- Other names
- cyproheptadine + tricholine citrate + sorbitolcyproheptadine, sorbitol and tricholine citratecyproheptadine, tricholine citrate and sorbitol
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))HTR2A (Serotonin receptor 5-HT2A)HTR2B (5-Hydroxytryptamine Receptor 2B)HTR2C (5-hydroxytryptamine 2C receptor)AR (Adrenergic receptors)HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)
Beyond the preview
Go deeper on cyproheptadine + sorbitol + tricholine citrate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cyproheptadine + sorbitol + tricholine citrate.